Efficacy of transdermal nitroglycerin patches evaluated by dipyridamole-induced myocardial ischemia in patients with coronary artery disease. Comparison between continuous and intermittent schedule

Cardiovascular Drugs and Therapy

Volumn 16, Issue 6, 2002, Pages 535-542

  Longobardi, Giancarlo ^a   Ferrara, Nicola ^a,c   Abete, Pasquale ^b   Leosco, Dario ^b   Furgi, Giuseppe ^a   Nicolino, Antonio ^a   Vitale, Dino Franco ^a   Rengo, Franco ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Coronary artery disease; Dipyridamole echocardiographic test; Nitrate tolerance; Nitroglycerin

Indexed keywords

DIPYRIDAMOLE; GLYCERYL TRINITRATE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG TOLERANCE; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HEART VENTRICLE WALL MOTION; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STRESS ECHOCARDIOGRAPHY;

ADMINISTRATION, CUTANEOUS; AGED; CORONARY ARTERIOSCLEROSIS; CROSS-OVER STUDIES; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0036996327     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022963103914     Document Type: Article

References (37)

1. Thadani U, Fung H-L, Darke AG, Parker JO. Oral isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 1982;49:411.
2. Dalal JJ, Yao L, Parker JO. Nitrate tolerance: Influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol 1983;2:115.
3. Thadani U, Manyari D, Parker JO. Tolerance to the circulatory effects of oral isosorbide dinitrate: Rate of development and cross-tolerance to glyceryn trinitrate. Circulation 1980;61:526.
4. Parker JO, VanKoughnett KA, Fung H-L. Transdermal isosorbide dinitrate in angina pectoris: Effect of acute and sustained therapy. Am J Cardiol 1984;54:8.
5. Parker JO, Fung H-L. Transdermal nitroglycerin in angina pectoris. Am J Cardiol 1984;54:471.
6. Parker JO, VanKoughnett KA, Farrel B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am J Cardiol 1985;56:724.
7. Parker JO, Fung H-L, Ruggirello D, Stone JA. Tolerance to isosorbide dinitrate: Rate of development and reversal. Circulation 1983;68:1074-1080.
8. Parker JO. Nitrate therapy in stable angina pectoris. N Engl J Med 1987;316:1635-1642.
9. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.
10. Dupuis J, Lalonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-Acetylcysteine. J Am Coll Cardiol 1990;16:923-931.
11. Ferrantini M, Pirelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. Eur Heart J 1989;10:998-1002.
12. Parker JO, Amies MA, Hawkinson RW, et al. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Circulation 1995;91:1368-1374.
13. Redwood DR, Rosing DR, Goldstein RE, Beiser GD, Epstein SE. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation 1971;43:618-628.
14. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's angina: Role of exercise-induced coronary arterial spasm. Circulation 1979;59:938-948.
15. Tomai F, Crea F, Danesi A, et al. Mechanisms of the warm-up phenomenon. Eur Heart J 1996;17:1022-1027.
16. Okazaki Y, Kodama K, Sato H, et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 1993;21:1597-1604.
17. Marber RS, Joy MD, Yellon DM. Is warm-up in angina ischemic preconditioning? Br Heart J 1994;72:213-215.
18. Ferrara N, Bonaduce D, Leosco D, et al. Two-dimensional echocardiographic evaluation of ventricular asynergy by dipyridamole: Correlation with thallium scanning. Clin Cardiol 1986;9:437-442.
19. Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L'Abbate A. Dipyridamole-echocardiography test in effort angina pectoris. Am J Cardiol 1985;56:452-456.
20. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848-854.
21. Picano E. Dipyridamole-echocardiography test: Historical background and physiologic basis. Eur Heart J 1989;10:365-366.
22. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991;83:1256-1262.
23. Ferrara N, Longobardi G, Nicolino A, et al. Effect of betaadrenoceptor blockade on dipyridamole induced myocardial asynergies in coronary artery disease. Am J Cardiol 1992;70:724-727.
24. Longobardi G, Ferrara N, Leosco D, et al. Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia. Am J Cardiol 1995;76:255-258.
25. Ferrara N, Longobardi G, Leosco D, et al. Verapamil reduces dipyridamole-induced myocardial ischemia in patients with coronary artery disease. J Cardiovasc Pharmacol 1999;33:383-387.
26. Longobardi G, Ferrara N, Leosco D, et al. Echodipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease. Interplay with sympathetic activity. J Cardiovasc Pharmacol 2000;36:50-55.
27. Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: The GISSI trial. J Am Coll Cardiol 1989;14:1149-1158.
28. GISSI 2: Sottoprogetto ischemia residua. G It Cardiol 1988;18:758-763.
29. Marangelli V, D'Ambrosio G, Carella L, Iliceto S, Rizzon P. Digital cine-loop technology. A new tool for the evaluation of wall motion abnormalities. In: Iliceto S, Rizzon P, Roelandt JRTC, eds. Ultrasound in Coronary Artery Disease. Present Role and Future Perspectives. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1991:145-158.
30. Needleman P, Johnson EM Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184:709-715.
31. Kurz S, Hink U, Nickenig G, et al. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance. Circulation 1999;99:3181-3187.
32. Parker JD, Farrell B, Fenton T, et al. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 1991;84:2336-2345.
33. Münzel T, Sayegh H, Freeman BA, et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: A novel mechanism underling tolerance and cross-tolerance. J Clin Invest 1995;95:187-194.
34. Münzel T, Giaid A, Kurz S, et al. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci 1995;92(11):5244-5248.
35. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. New Engl J Med 1998;338:520-531.
36. Flaherty JT. Nitrate tolerance. A review of the evidence. Drugs 1989;37:523-550.
37. Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 1976;54:766-773.